Skip to main content

Poseida Therapeutics, Inc.

PSTXDelisted Jan 8, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001661460

Poseida Therapeutics, Inc. was delisted on Jan 8, 2025; its insiders filed their last Form 4 on Jan 10, 2025; 116 institutions reported holding it in 13F filings for Q4 2024, worth $519.2M in total; no superinvestor held it.

13F holders, Q4 2024

Institutional positions in Poseida Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

PSTX is no longer listed, so this page shows Q4 2024. 13F filings for later quarters list far fewer holders.

Institutional holders
116
+20 vs. Q3 2024
Shares held
54.1M
+458.4K (+0.9%) vs. Q3 2024
Total value
$519.2M
+$365.8M (+238.5%) vs. Q3 2024
New holders
46
31 more added
Sold out
26
27 more reduced

Compare with Q3 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PSTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2024: 116 institutions
Q1 2021: 62 institutionsQ2 2021: 71 institutionsQ3 2021: 65 institutionsQ4 2021: 66 institutionsQ1 2022: 64 institutionsQ2 2022: 56 institutionsQ3 2022: 68 institutionsQ4 2022: 89 institutionsQ1 2023: 102 institutionsQ2 2023: 94 institutionsQ3 2023: 86 institutionsQ4 2023: 91 institutionsQ1 2024: 91 institutionsQ2 2024: 93 institutionsQ3 2024: 96 institutionsQ4 2024: 116 institutionsQ1 2025: 2 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2024: $519.2M
Q1 2021: $276.3MQ2 2021: $279.3MQ3 2021: $190.7MQ4 2021: $178.4MQ1 2022: $108.4MQ2 2022: $58.1MQ3 2022: $141.8MQ4 2022: $227.6MQ1 2023: $136.0MQ2 2023: $78.4MQ3 2023: $107.6MQ4 2023: $152.4MQ1 2024: $168.6MQ2 2024: $154.9MQ3 2024: $153.4MQ4 2024: $519.2MQ1 2025: $308.0KQ2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding PSTX and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20252$308.0K
Q4 2024116$519.2M
Q3 202496$153.4M
Q2 202493$154.9M
Q1 202491$168.6M
Q4 202391$152.4M
Q3 202386$107.6M
Q2 202394$78.4M
Q1 2023102$136.0M
Q4 202289$227.6M
Q3 202268$141.8M
Q2 202256$58.1M
Q1 202264$108.4M
Q4 202166$178.4M
Q3 202165$190.7M
Q2 202171$279.3M
Q1 202162$276.3M

Institutions, Q4 2024

Shares, value and share of portfolio for each institution holding Poseida Therapeutics, Inc.; share changes are against Q3 2024.

Institutions holding PSTX in Q4 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Glazer Capital, LLC521,113$5.00M0.34%+521,113New
Northern Trust Corp571,093$5.48M0.00%+5,706+1.0%Added
Charles Schwab Investment Management Inc589,007$5.65M0.00%+21,944+3.9%Added
TIG Advisors, LLC685,595$6.58M0.51%+685,595New
Acadian Asset Management LLC933,102$8.96M0.03%+102,061+12.3%Added
Silverarc Capital Management, LLC1,012,307$9.72M2.17%−2,675,241−72.5%Reduced
Aisling Capital Management LP1,043,267$10.0M3.55%00.0%Unchanged
State Street Corp1,594,542$15.3M0.00%−116,023−6.8%Reduced
Geode Capital Management, LLC1,629,759$15.6M0.00%+12,622+0.8%Added
Boxer Capital Management, LLC2,000,000$19.2M1.63%+2,000,000New
Alpine Associates Management Inc.2,016,700$19.4M1.18%+2,016,700New
Vanguard Group Inc3,834,519$36.8M0.00%+171,063+4.7%Added
Nomura Holdings Inc5,115,015$49.1M0.26%+5,115,015New
BlackRock, Inc.5,631,488$54.1M0.00%+507,519+9.9%Added
Pentwater Capital Management LP8,625,000$82.8M1.43%+2,650,000+44.4%Added
FMR LLC10,011,617$96.1M0.01%−4,558,461−31.3%Reduced
Boxer Capital, LLC0$00.00%−2,000,000−100.0%Sold out
Blair William & Co0$00.00%−1,112,140−100.0%Sold out
Jacobs Levy Equity Management, Inc0$00.00%−811,512−100.0%Sold out
Woodline Partners LP0$00.00%−478,861−100.0%Sold out
Ameriprise Financial Inc0$00.00%−134,852−100.0%Sold out
Fred Alger Management, LLC0$00.00%−128,970−100.0%Sold out
Callan Capital, LLC0$00.00%−108,080−100.0%Sold out
Advantage Alpha Capital Partners LP0$00.00%−99,566−100.0%Sold out
Privium Fund Management B.V.0$00.00%−77,500−100.0%Sold out
Public Employees Retirement System of Ohio0$00.00%−59,354−100.0%Sold out
HSBC Holdings PLC0$00.00%−58,530−100.0%Sold out
Bridgeway Capital Management, LLC0$00.00%−43,600−100.0%Sold out
Cornercap Investment Counsel Inc0$00.00%−43,177−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−37,400−100.0%Sold out
Man Group plc0$00.00%−34,171−100.0%Sold out
Forefront Analytics, LLC0$00.00%−27,855−100.0%Sold out
Russell Investments Group, Ltd.0$00.00%−20,566−100.0%Sold out
State of Wyoming0$00.00%−18,749−100.0%Sold out
Mackenzie Financial Corp0$00.00%−17,616−100.0%Sold out
Keystone Financial Group0$00.00%−15,000−100.0%Sold out
Virtu Financial LLC0$00.00%−13,035−100.0%Sold out
Sherbrooke Park Advisers LLC0$00.00%−10,696−100.0%Sold out
Optimum Investment Advisors0$00.00%−2,000−100.0%Sold out
Voisard Asset Management Group, Inc.0$00.00%−270−100.0%Sold out
SRS Capital Advisors, Inc.0$00.00%−38−100.0%Sold out
Allspring Global Investments Holdings, LLC0$00.00%−34−100.0%Sold out